scispace - formally typeset
V

Vladimir Brusic

Researcher at Nazarbayev University

Publications -  224
Citations -  14646

Vladimir Brusic is an academic researcher from Nazarbayev University. The author has contributed to research in topics: Epitope & Antigen. The author has an hindex of 50, co-authored 212 publications receiving 13727 citations. Previous affiliations of Vladimir Brusic include Griffith University & Harvard University.

Papers
More filters
Journal ArticleDOI

Pathogenic human thyroglobulin peptides in HLA-DR3 transgenic mouse model of autoimmune thyroiditis

TL;DR: In this paper, a computer-based algorithm was used to predict potential HLA-DR3-binding peptides and have tested them in DR3-transgenic mice, and the results demonstrate the utility of using this algorithm with synthetic peptides to help identify pathogenic T cell epitopes on hTg.
Journal ArticleDOI

Serologic Markers of Effective Tumor Immunity against Chronic Lymphocytic Leukemia Include Nonmutated B-Cell Antigens

TL;DR: The antigenic basis of the effective graft-versus-leukemia (GvL) responses associated with DLI for the treatment of CLL is elucidated by analyzing the specificity of plasma antibody responses developing in two DLI-treated patients who achieved long-term remission without graft-Versus-host disease.
Journal ArticleDOI

Pathway analysis and transcriptomics improve protein identification by shotgun proteomics from samples comprising small number of cells - a benchmarking study

TL;DR: The comparison of proteomics and transcriptomics data, suggests that highly expressed transcripts have high probability of protein expression, however, approximately 10% of expressed proteins could not be matched with the expressed transcripts.
Journal ArticleDOI

Ultra-high resolution HLA genotyping and allele discovery by highly multiplexed cDNA amplicon pyrosequencing

TL;DR: A cDNA amplicon-based pyrosequencing method to capture 94% of the HLA class I open-reading-frame with only two amplicons per sample, and an analogous method for class II HLA genes, with a primary focus on sequencing the DRB loci, are designed.